BioCentury
ARTICLE | Company News

Odyssey, Merck deal

October 18, 2004 7:00 AM UTC

Under an expansion of an existing deal, Odyssey will use its protein-fragmentation complementation assay (PCA) and high throughput systems biology to characterize the mechanisms of action in human cel...